- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02226016
Levator Muscle Strength Evaluation
Quantitative Evaluation of Levator Palpebra Muscle Strength
The purpose of this study is to assess a new technique of measurement for the levator muscle.
this measurement may be applied during a clinical evaluation of eyelid malposition.
our purpose is to quantify the levator muscle strength and to corelate it to standard levator muscle strength assessment techniques routinley used in the oculoplastic clinic.
Study Overview
Detailed Description
This study will include patients refered to our oculoplastic department for evaluation of eyelid disorders (ptosis or eyelid malpositions due to various mechanical, muscular, neurogenic factors).
all patients will be over 21 years old, with eligibility for signing an informed concent form.
all patients will undergo a full clinical standard evaluation of eyelid malposition made as part of the routine evaluation of eyelid malpositions. as part of this evaluation- the levator muscles strength will be measured by monitoring the amount of millimeters of difference between the uper lid closed and open position (a regular technique for levator muscles assessment).
a second levator muscle strength evaluation will include the study device. this device is used for weight evaluation of objects. an object is measured by attaching it to the device with a metal hook and a string. the device is hand held.
for measurements of the upper lid force the device will be temporarily attached to the upper eyelid using a specially designed base made in the shape of the eyelid. the attachment will be using a sterile medical tape (plaster). this sterile base is attached to the outer eyelid and does not involve in any point any harm to the continuity of the skin, injections , harm or contact to the eyeball or any other parts of the eye. this base is attached from its back to a string witch attaches to the measuring device. the investigator holds the measuring device and asks the patient to open and close his eyes. the force that is generated while opening the upper lid is measured (in grams) by the device.
this evaluation will allow a unique first proper estimation of the true levator palpebra strength. it will be compared to the levators' strength as estimated using the routine techniques for assessing their efficacy.
the assessment will be made one time for each patient. after the measurement- the sterile tape will be removed and will be disposed. no further interventions will be made for each patient.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Nemet Arik, DR
- Phone Number: +972-9747-2154
- Email: nemet.arik@gmail.com
Study Contact Backup
- Name: Ofir Shay, DR
- Phone Number: +972-9747-2154
- Email: shayofir1@gmail.com
Study Locations
-
-
-
Kfar Saba, Israel
- Meir Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
eligible for signing an informed concent form refered for eyelid evaluation in the oculoplastic department, Meir Mc
Exclusion Criteria:
previous eyelid surgery
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Ptosis
Device (measurement of levator strength in patients with upper lid ptosis)
|
a measuring device for the assessment of levator muscle strength
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
levator muscle strength quantified in grams using a unique measuring device.
Time Frame: each patient will undergo two measurments of the levator muscle strength using the study device during a single clinical evaluation. no further evaluations will be made for the same patient throughout the study.
|
we aim to accurately measure the levator muscle strength in grams.
the levator muscle will be noninvasively attached to the device using a string.
while changing eye position from closure to opening- the force generated by the eyelid will be reflected through the string to the measuring device and will be displayed in grams.
this will reflect the levator muscles strength.
|
each patient will undergo two measurments of the levator muscle strength using the study device during a single clinical evaluation. no further evaluations will be made for the same patient throughout the study.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
repeatability of the measurements
Time Frame: each patient will undergo two measurments of the levator muscle strength using the study device during a single clinical evaluation. no further evaluations will be made for the same patient throughout the study.
|
we wish to evaluate the validity of these muscle strength assessments.
for each patient two muscle measurements will be done by a single clinician.
their results will be furtherly assessed for repeatability of the measurement.
|
each patient will undergo two measurments of the levator muscle strength using the study device during a single clinical evaluation. no further evaluations will be made for the same patient throughout the study.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Arik Nemet, Dr, Meir Medical Center
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LEVATOR01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ptosis
-
Kenneth BeerMedicis Pharmaceutical CorporationCompleted
-
Zift, LLCLibra MedicalTerminatedSenile PtosisUnited States
-
Meir Medical CenterUnknown
-
Maastricht University Medical CenterWithdrawn
-
Ain Shams UniversityCompletedMild Ptosis | Moderate PtosisEgypt
-
Sheba Medical CenterUnknownSurgical Procedure, Unspecified | Ptosis, Eyelid | Ptosis; Eyelid, CongenitalIsrael
-
1st SurgiConceptEVAMEDRecruiting
-
The New York Eye & Ear InfirmaryCompleted
-
Sohag UniversityNot yet recruitingCongenital PtosisEgypt
-
Shanghai Jiao Tong University School of MedicineUnknown
Clinical Trials on FG-5000A
-
Guili WangRecruiting
-
University of MinnesotaCompletedPhysical Activity | Technology | Intervention | Behavior Change | Young AdultsUnited States
-
FibroGenTerminatedFocal Segmental GlomerulosclerosisUnited States
-
FibroGenCompletedDiabetes MellitusUnited States
-
FibroGenAstraZenecaWithdrawnAnemia Associated With Chronic Kidney DiseaseUnited States
-
FibroGenAstraZeneca; Astellas Pharma IncCompletedChemotherapy Induced AnemiaUnited States
-
FibroGenCompletedAnemia in Chronic Kidney DiseaseChina
-
Astellas Pharma Europe B.V.FibroGenCompletedImpaired Renal Function | Normal Renal FunctionGermany, United Kingdom
-
FibroGenTerminatedIdiopathic Pulmonary FibrosisUnited States, China, Australia, Korea, Republic of, Taiwan, Russian Federation, Hong Kong, Argentina, Chile
-
FibroGenCompleted